LRRTM1 Antibodies

Santa Cruz Biotechnology features a diverse variety of LRRTM1 monoclonal antibodies for research focused on understanding LRRTM1's role in various biological processes. LRRTM1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRTM1, or Leucine-rich repeat transmembrane neuronal 1, is a protein that plays a critical role in synapse formation and function in the nervous system. LRRTM1 is involved in the regulation of neurotransmitter release and is essential for proper neuronal communication. Dysregulation of LRRTM1 has been implicated in various neurodevelopmental disorders, making it a significant target for research in neuroscience. Research with LRRTM1 monoclonal antibodies enables detailed investigation of synaptic development and maintenance. Understanding LRRTM1's molecular interactions provides crucial information about neural circuit formation. Investigating LRRTM1 expression patterns helps reveal its distribution across different brain regions and developmental stages. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of neurological development and disease mechanisms.